Salt Lake City, UT (PRWEB) October 10, 2022 EVŌQ Bio (an EVŌQ Nano company), a nano-platform technology company, is pleased to announce their attendance at
A preclinical study in hamsters showed both a decrease in infectious virus and in transmission Phase 1 data measuring cross-reactivity also included in.